Related Experiment Video
Updated: May 31, 2026
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
A retrospective study comparing hypofractionated radiotherapy and conventional radiotherapy in postmastectomy breast
Attapol Pinitpatcharalert1, Imjai Chitapanarux, Juntima Euathrongchit
1Division of Therapeutic Radiology and Oncology, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand. benzai.25@gmail.com
Background:
The conventional radiotherapy (CRT) in postmastectomy breast cancer is 1.8-2.0 Gy daily for 25 fractions, while hypofractionated radiotherapy (HFRT) delivered dose in fewer fractions with larger radiation intensity. The present study compares the efficacy of HFRT and CRT.
Material And Method:
From 2004 to 2006, 215 patients were retrospectively reviewed. Sixty seven patients received CRT and 148 patients received HFRT (2.65 Gy in 16-18 fractions). Five-year locoregional control (LRC), disease free survival (DFS), overall survival (OS) and toxicities were analyzed.
Results:
Median follow-up was 39 months. Five-year LRC was 86.6% in CRT and 85.8% in HFRT (p = 0.852). Five-year DFS was 62.7% and 69.6% (p = 0.136) in CRTand HFRT respectively. Patients who received HFRT had significant increase in 5-year OS (62.7% and 73.0% (p = 0.048). No difference of toxicities including changes in chest wall appearance, skin fibrosis, brachial plexopathy, arm edema, pulmonary fibrosis, rib fractures and cardiovascular events was found between two groups.
Conclusion:
HFRT is as effective as CRT in postmastectomy breast cancer.
